Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01TLN
|
||||
| Former ID |
DNC014186
|
||||
| Drug Name |
9-O-[4-(Phenylol-1-yloxy)butyl]berberine bromide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530625] | ||
| Formula |
C29H28BrNO5
|
||||
| Canonical SMILES |
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCC<br />OC6=CC=CC=C6.[Br-]
|
||||
| InChI |
1S/C29H28NO5.BrH/c1-31-26-10-9-20-15-25-23-17-28-27(34-19-35-28)16-21(23)11-12-30(25)18-24(20)29(26)33-14-6-5-13-32-22-7-3-2-4-8-22;/h2-4,7-10,15-18H,5-6,11-14,19H2,1H3;1H/q+1;/p-1
|
||||
| InChIKey |
RGAFBRYQCWMODS-UHFFFAOYSA-M
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530625] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530625] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||